In three mouse models of breast cancer, we show reduced responses to neoadjuvant chemotherapy when treatment is initiated during the dioestrus stage, when compared with initiation during the oestrus stage.
- Laura Bornes
- Lennart J. van Winden
- Jacco van Rheenen